335 related articles for article (PubMed ID: 18554313)
21. Cross-resistance to polyene and azole drugs in Cryptococcus neoformans.
Joseph-Horne T; Hollomon D; Loeffler RS; Kelly SL
Antimicrob Agents Chemother; 1995 Jul; 39(7):1526-9. PubMed ID: 7492098
[TBL] [Abstract][Full Text] [Related]
22. Antimicrobial Octapeptin C4 Analogues Active against Cryptococcus Species.
Chitty JL; Butler MS; Suboh A; Edwards DJ; Cooper MA; Fraser JA; Robertson AAB
Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158283
[TBL] [Abstract][Full Text] [Related]
23. Specific antibody to Cryptococcus neoformans glucurunoxylomannan antagonizes antifungal drug action against cryptococcal biofilms in vitro.
Martinez LR; Christaki E; Casadevall A
J Infect Dis; 2006 Jul; 194(2):261-6. PubMed ID: 16779734
[TBL] [Abstract][Full Text] [Related]
24. 3-Bromopyruvate: a novel antifungal agent against the human pathogen Cryptococcus neoformans.
Dyląg M; Lis P; Niedźwiecka K; Ko YH; Pedersen PL; Goffeau A; Ułaszewski S
Biochem Biophys Res Commun; 2013 May; 434(2):322-7. PubMed ID: 23541578
[TBL] [Abstract][Full Text] [Related]
25. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
26. Host Carbon Dioxide Concentration Is an Independent Stress for Cryptococcus neoformans That Affects Virulence and Antifungal Susceptibility.
Krysan DJ; Zhai B; Beattie SR; Misel KM; Wellington M; Lin X
mBio; 2019 Jul; 10(4):. PubMed ID: 31266878
[TBL] [Abstract][Full Text] [Related]
27. Identification and properties of plasma membrane azole efflux pumps from the pathogenic fungi Cryptococcus gattii and Cryptococcus neoformans.
Basso LR; Gast CE; Bruzual I; Wong B
J Antimicrob Chemother; 2015 May; 70(5):1396-407. PubMed ID: 25630649
[TBL] [Abstract][Full Text] [Related]
28. Dissociation of a hydrophobic surface from phagocytosis of encapsulated and non-encapsulated cryptococcus neoformans.
Kozel TR
Infect Immun; 1983 Mar; 39(3):1214-9. PubMed ID: 6341232
[TBL] [Abstract][Full Text] [Related]
29. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide.
Granger DL; Perfect JR; Durack DT
J Clin Invest; 1985 Aug; 76(2):508-16. PubMed ID: 3928681
[TBL] [Abstract][Full Text] [Related]
30. Hrk1 plays both Hog1-dependent and -independent roles in controlling stress response and antifungal drug resistance in Cryptococcus neoformans.
Kim SY; Ko YJ; Jung KW; Strain A; Nielsen K; Bahn YS
PLoS One; 2011 Apr; 6(4):e18769. PubMed ID: 21533251
[TBL] [Abstract][Full Text] [Related]
31. Cryptococcus neoformans phosphoinositide-dependent kinase 1 (PDK1) ortholog is required for stress tolerance and survival in murine phagocytes.
Chabrier-Roselló Y; Gerik KJ; Koselny K; DiDone L; Lodge JK; Krysan DJ
Eukaryot Cell; 2013 Jan; 12(1):12-22. PubMed ID: 23087368
[TBL] [Abstract][Full Text] [Related]
32. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
Rossato L; Loreto ÉS; Venturini TP; Azevedo MI; Weiblen C; Botton SA; Santurio JM; Alves SH
Med Mycol; 2015 Nov; 53(8):885-9. PubMed ID: 26333356
[TBL] [Abstract][Full Text] [Related]
33. The volume and hydration of the Cryptococcus neoformans polysaccharide capsule.
Maxson ME; Cook E; Casadevall A; Zaragoza O
Fungal Genet Biol; 2007 Mar; 44(3):180-6. PubMed ID: 16963294
[TBL] [Abstract][Full Text] [Related]
34. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin.
van Duin D; Casadevall A; Nosanchuk JD
Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341
[TBL] [Abstract][Full Text] [Related]
35. Comparative antifungal susceptibility analyses of Cryptococcus neoformans VNI and Cryptococcus gattii VGII from the Brazilian Amazon Region by the Etest, Vitek 2, and the Clinical and Laboratory Standards Institute broth microdilution methods.
Nishikawa MM; Almeida-Paes R; Brito-Santos F; Nascimento CR; Fialho MM; Trilles L; Morales BP; da Silva SA; Santos W; Santos LO; Fortes ST; Cardarelli-Leite P; Lázera MDS
Med Mycol; 2019 Oct; 57(7):864-873. PubMed ID: 30657975
[TBL] [Abstract][Full Text] [Related]
36. A Novel Protocol for the Isolation of Fungal Extracellular Vesicles Reveals the Participation of a Putative Scramblase in Polysaccharide Export and Capsule Construction in
Reis FCG; Borges BS; Jozefowicz LJ; Sena BAG; Garcia AWA; Medeiros LC; Martins ST; Honorato L; Schrank A; Vainstein MH; Kmetzsch L; Nimrichter L; Alves LR; Staats CC; Rodrigues ML
mSphere; 2019 Mar; 4(2):. PubMed ID: 30894430
[TBL] [Abstract][Full Text] [Related]
37. Phagocytosis of Cryptococcus neoformans by, and nonlytic exocytosis from, Acanthamoeba castellanii.
Chrisman CJ; Alvarez M; Casadevall A
Appl Environ Microbiol; 2010 Sep; 76(18):6056-62. PubMed ID: 20675457
[TBL] [Abstract][Full Text] [Related]
38. Effects of microplusin, a copper-chelating antimicrobial peptide, against Cryptococcus neoformans.
Silva FD; Rossi DC; Martinez LR; Frases S; Fonseca FL; Campos CB; Rodrigues ML; Nosanchuk JD; Daffre S
FEMS Microbiol Lett; 2011 Nov; 324(1):64-72. PubMed ID: 22092765
[TBL] [Abstract][Full Text] [Related]
39. Global transcriptome profile of Cryptococcus neoformans during exposure to hydrogen peroxide induced oxidative stress.
Upadhya R; Campbell LT; Donlin MJ; Aurora R; Lodge JK
PLoS One; 2013; 8(1):e55110. PubMed ID: 23383070
[TBL] [Abstract][Full Text] [Related]
40. Isolation and characterization of Cryptococcus neoformans spores reveal a critical role for capsule biosynthesis genes in spore biogenesis.
Botts MR; Giles SS; Gates MA; Kozel TR; Hull CM
Eukaryot Cell; 2009 Apr; 8(4):595-605. PubMed ID: 19181873
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
